taxonomy (2)
protein (4)
source (1)
structure (53)
composition (38)
disease (3)
reference (10)
site (5)
peptide (1)
- Homo sapiens (Human)
- Bos taurus (Bovine)
Taxonomy
- Bile-salt-activated lipase / Homo sapiens P19835
- Chymotrypsin-like elastase family member 3B / Homo sapiens P08861
- Pancreatic glycopeptides / Homo sapiens
- Ribonuclease pancreatic [b] / Bos taurus P61823
Protein
- Pancreas (UBERON_0001264)
Source
- N-Linked / Complex / GlcNAc(b1-2)Man(a1-6)[Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / GlcNAc(b1-2)Man(a1-3)[GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Fuc(a1-2)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Fuc(a1-?)[Gal(b1-?)]GlcNAc(b1-2)Man(a1-3)[GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Fuc(a1-2)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ NeuAc"
- N-Linked / Complex / Fuc(a1-2)[Gal(a1-3)]Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Fuc(a1-2)Gal(b1-4)GlcNAc(b1-2)Man(a1-?)[Gal(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Fuc(a1-?)[Gal(b1-?)]GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Fuc(a1-2)[GalNAc(a1-3)]Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)][GlcNAc(b1-4)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ NeuAc"
- N-Linked / Complex / Fuc(a1-2)[Gal(a1-3)]Gal(b1-?)[Fuc(a1-?)]GlcNAc(b1-2)Man(a1-3)[GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Fuc(a1-2)[Gal(a1-3)]Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Fuc(a1-2)[GalNAc(a1-3)]Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Man(a1-2)Man(a1-3)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Fuc(a1-2)[GalNAc(a1-3)]Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Fuc(a1-2)[GalNAc(a1-3)]Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[GlcNAc(b1-2)Man(a1-6)][GlcNAc(b1-4)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / NeuAc(a2-?)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[NeuAc(a2-?)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Fuc(a1-2)[Gal(a1-3)]Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[Fuc(a1-2)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Fuc(a1-2)[GalNAc(a1-3)]Gal(b1-?)[Fuc(a1-?)]GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Fuc(a1-2)[GalNAc(a1-3)]Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)][GlcNAc(b1-4)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / NeuAc(a2-?)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[NeuAc(a2-?)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Fuc(a1-2)[Gal(a1-3)]Gal(b1-4)GlcNAc(b1-4)[Fuc(a1-2)Gal(b1-4)GlcNAc(b1-2)]Man(a1-3)[Fuc(a1-2)[Gal(a1-3)]Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Fuc(a1-2)[Gal(a1-3)]Gal(b1-4)GlcNAc(b1-2)[Fuc(a1-2)Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)[Fuc(a1-2)[Gal(a1-3)]Gal(b1-4)GlcNAc(b1-4)[Fuc(a1-2)Gal(b1-4)GlcNAc(b1-2)]Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / High-Mannose / Man(a1-3)[Man(a1-6)]Man(a1-6)[Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / High-Mannose / Man(a1-3)[Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 2 x Man"
- N-Linked / High-Mannose / Man(a1-3)[Man(a1-6)]Man(a1-6)[Man(a1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / High-Mannose / Man(a1-3)[Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 3 x Man"
- N-Linked / High-Mannose / Man(a1-2)Man(a1-3)[Man(a1-6)]Man(a1-6)[Man(a1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / High-Mannose / Man(a1-2)Man(a1-6)[Man(a1-3)]Man(a1-6)[Man(a1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / High-Mannose / Man(a1-3)[Man(a1-6)]Man(a1-6)[Man(a1-2)Man(a1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / High-Mannose / Man(a1-3)[Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 4 x Man"
- N-Linked / High-Mannose / Man(a1-2)Man(a1-3)[Man(a1-2)Man(a1-6)]Man(a1-6)[Man(a1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / High-Mannose / Man(a1-2)Man(a1-3)[Man(a1-6)]Man(a1-6)[Man(a1-2)Man(a1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / High-Mannose / Man(a1-2)Man(a1-6)[Man(a1-3)]Man(a1-6)[Man(a1-2)Man(a1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / High-Mannose / Man(a1-3)[Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 5 x Man"
- N-Linked / High-Mannose / Man(a1-2)Man(a1-3)[Man(a1-2)Man(a1-6)]Man(a1-6)[Man(a1-2)Man(a1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / High-Mannose / Man(a1-3)[Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 6 x Man"
- N-Linked / Hybrid / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Man(a1-3)[Man(a1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / No-core / GlcNAc(b1-2)Man(a1-3)[GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc
- N-Linked / No-core / GlcNAc(b1-2)[GlcNAc(b1-4)]Man(a1-3)[GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc
- N-Linked / No-core / GlcNAc(b1-2)Man(a1-3)[GlcNAc(b1-4)][GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc
- N-Linked / Pauci-Mannose / Man(a1-3)[Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- O-Linked / Core 1 / Gal(b1-3)GalNAc+"+ NeuAc"
- O-Linked / Core 1 / Gal(b1-3)GalNAc+"+ Fuc + NeuAc"
- O-Linked / Core 1 / Gal(b1-3)GalNAc+"+ 2 x NeuAc"
Reported structure
- Hex:1 HexNAc:1 NeuAc:1 (avg mass : 674.6106 )
- Hex:1 HexNAc:1 NeuAc:2 (avg mass : 965.8685 )
- Hex:1 HexNAc:1 dHex:1 NeuAc:1 (avg mass : 820.7536 )
- Hex:3 HexNAc:2 dHex:1 (avg mass : 1056.9755 )
- Hex:3 HexNAc:3 (avg mass : 1114.0275 )
- Hex:3 HexNAc:3 dHex:1 (avg mass : 1260.1705 )
- Hex:3 HexNAc:4 (avg mass : 1317.2225 )
- Hex:3 HexNAc:4 dHex:1 (avg mass : 1463.3655 )
- Hex:4 HexNAc:3 dHex:1 (avg mass : 1422.3129 )
- Hex:4 HexNAc:4 (avg mass : 1479.3649 )
- Hex:4 HexNAc:4 dHex:1 (avg mass : 1625.5079 )
- Hex:4 HexNAc:4 dHex:2 (avg mass : 1771.6509 )
- Hex:4 HexNAc:5 dHex:2 (avg mass : 1974.8459 )
- Hex:4 HexNAc:6 dHex:2 (avg mass : 2178.0409 )
- Hex:5 HexNAc:2 (avg mass : 1235.1173 )
- Hex:5 HexNAc:4 (avg mass : 1641.5073 )
- Hex:5 HexNAc:4 NeuAc:1 (avg mass : 1932.7652 )
- Hex:5 HexNAc:4 NeuAc:2 (avg mass : 2224.0231 )
- Hex:5 HexNAc:4 dHex:1 (avg mass : 1787.6503 )
- Hex:5 HexNAc:4 dHex:1 NeuAc:1 (avg mass : 2078.9082 )
- Hex:5 HexNAc:4 dHex:1 NeuAc:2 (avg mass : 2370.1661 )
- Hex:5 HexNAc:4 dHex:2 (avg mass : 1933.7933 )
- Hex:5 HexNAc:4 dHex:3 (avg mass : 2079.9363 )
- Hex:5 HexNAc:5 dHex:1 (avg mass : 1990.8453 )
- Hex:5 HexNAc:5 dHex:2 (avg mass : 2136.9883 )
- Hex:5 HexNAc:5 dHex:3 (avg mass : 2283.1313 )
- Hex:5 HexNAc:6 dHex:2 (avg mass : 2340.1833 )
- Hex:6 HexNAc:2 (avg mass : 1397.2597 )
- Hex:6 HexNAc:3 (avg mass : 1600.4547 )
- Hex:6 HexNAc:3 dHex:1 (avg mass : 1746.5977 )
- Hex:6 HexNAc:4 dHex:2 (avg mass : 2095.9357 )
- Hex:6 HexNAc:4 dHex:3 (avg mass : 2242.0787 )
- Hex:6 HexNAc:5 (avg mass : 2006.8447 )
- Hex:7 HexNAc:2 (avg mass : 1559.4021 )
- Hex:8 HexNAc:2 (avg mass : 1721.5445 )
- Hex:8 HexNAc:5 dHex:4 (avg mass : 2915.7015 )
- Hex:9 HexNAc:2 (avg mass : 1883.6869 )
- Hex:9 HexNAc:6 dHex:5 (avg mass : 3427.1819 )
Composition
- Cancer, Bile duct (DOID:4606)
- Gangliosidosis GM2, Sandhoff Disease (DOID:3323)
- Pancreatitis, Chronic (DOID:4989)
Disease
- Automated assignments of N- and O-site specific glycosylation with extensive glycan heterogeneity of glycoprotein mixtures (2013 - Strum JS1, Nwosu CC, Hua S, Kronewitter SR, Seipert RR, Bachelor RJ, An HJ, Lebrilla CB) / Status : Reviewed
- Site-specific glycoprofiling of N-linked glycopeptides using MALDI-TOF MS: strong correlation between signal strength and glycoform quantities. (2009 - Thaysen-Andersen M, Mysling S, Højrup P) / Status : Reviewed
- Tandem mass spectrometry of ribonuclease A and B: N-linked glycosylation site analysis of whole protein ions (2002 - Reid, Stephenson, McLuckey) / Status : Reviewed
- Analysis of carbohydrate heterogeneity in a glycoprotein using liquid chromatography/mass spectrometry and liquid chromatography with tandem mass spectrometry. (1999 - Kawasaki N, Ohta M, Hyuga S, Hashimoto O, Hayakawa T) / Status : Reviewed
- Chemical structure of the carbohydrate moiety of fucose-rich glycopeptides from human pancreatic juice. (1995 - Yoshihara S, Matsue H, Sasaki M, Shibata S, Konn M, Fukuzawa A, Endo M) / Status : Reviewed
- A detailed structural characterization of ribonuclease B oligosaccharides by 1H NMR spectroscopy and mass spectrometry. (1994 - Fu D, Chen L, O'Neill R) / Status : Reviewed
- The structure of N-linked oligosaccharides of human pancreatic bile-salt-dependent lipase. (1993 - Sugo T, Mas E, Abouakil N, Endo T, Escribano M, Kobata A, Lombardo D) / Status : Reviewed
- Variation of the glycosylation of human pancreatic bile-salt-dependent lipase. (1993 - Mas E, Abouakil N, Roudani S, Franc J, Montreuil J, Lombardo D) / Status : Reviewed
- Carbohydrate structure of human pancreatic elastase 1. (1991 - Wendorf P, Linder D, Sziegoleit A, Geyer R) / Status : Reviewed
- Characterization and analysis of branched-chain N-acetylglucosaminyl oligosaccharides accumulating in Sandhoff disease tissue. Evidence that biantennary bisected oligosaccharide side chains of glycoproteins are abundant substrates for lysosomes. (1985 - Warner TG, deKremer RD, Sjoberg ER, Mock AK) / Status : Reviewed
Reference
-
Bile-salt-activated lipase / Homo sapiens
- Undefined site
- Chymotrypsin-like elastase family member 3B / Homo sapiens
-
Pancreatic glycopeptides / Homo sapiens
- Undefined site
-
Ribonuclease pancreatic [b] / Bos taurus
- Undefined site
- Asn-60
Reported glycosite
- NLTKDR (6aa)
Mass spectrometry observed peptide
-
- N-Linked / Complex
(avg mass : 1260.1705)
- Pancreas (UBERON_0001264)
- Chymotrypsin-like elastase family member 3B / Homo sapiens
-
- N-Linked / Complex
(avg mass : 1422.3129)
- Pancreas (UBERON_0001264)
- Chymotrypsin-like elastase family member 3B / Homo sapiens
-
- N-Linked / Complex
(avg mass : 1463.3655)
- Pancreas (UBERON_0001264)
- Chymotrypsin-like elastase family member 3B / Homo sapiens
-
- N-Linked / Complex
(avg mass : 1479.3649)
- Pancreas (UBERON_0001264)
-
Bile-salt-activated lipase / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 1625.5079)
- Pancreas (UBERON_0001264)
-
Bile-salt-activated lipase / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 1625.5079)
- Pancreas (UBERON_0001264)
- Chymotrypsin-like elastase family member 3B / Homo sapiens
-
- N-Linked / Complex
(avg mass : 1625.5079)
- Pancreas (UBERON_0001264)
- Chymotrypsin-like elastase family member 3B / Homo sapiens
-
- N-Linked / Complex
(avg mass : 1641.5073)
- Pancreas (UBERON_0001264)
-
Bile-salt-activated lipase / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 1771.6509)
- Pancreas (UBERON_0001264)
- Chymotrypsin-like elastase family member 3B / Homo sapiens
-
- N-Linked / Complex
(avg mass : 1787.6503)
- Pancreas (UBERON_0001264)
-
Bile-salt-activated lipase / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 1787.6503)
- Pancreas (UBERON_0001264)
- The structure of N-linked oligosaccharides of human pancreatic bile-salt-dependent lipase. (1993 - Sugo T, Mas E, Abouakil N, Endo T, Escribano M, Kobata A, Lombardo D) / Status : Reviewed
- Carbohydrate structure of human pancreatic elastase 1. (1991 - Wendorf P, Linder D, Sziegoleit A, Geyer R) / Status : Reviewed
-
Bile-salt-activated lipase / Homo sapiens
- Undefined site
- Chymotrypsin-like elastase family member 3B / Homo sapiens
-
- N-Linked / Complex
(avg mass : 1932.7652)
- Pancreas (UBERON_0001264)
-
Bile-salt-activated lipase / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 1933.7933)
- Pancreas (UBERON_0001264)
- Chymotrypsin-like elastase family member 3B / Homo sapiens
-
- N-Linked / Complex
(avg mass : 1933.7933)
- Pancreas (UBERON_0001264)
-
Bile-salt-activated lipase / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 1933.7933)
- Pancreas (UBERON_0001264)
- Chymotrypsin-like elastase family member 3B / Homo sapiens
-
- N-Linked / Complex
(avg mass : 1974.8459)
- Pancreas (UBERON_0001264)
- Chymotrypsin-like elastase family member 3B / Homo sapiens
-
- N-Linked / Complex
(avg mass : 1990.8453)
- Pancreas (UBERON_0001264)
- Chymotrypsin-like elastase family member 3B / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2006.8447)
- Pancreas (UBERON_0001264)
-
Bile-salt-activated lipase / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2078.9082)
- Pancreas (UBERON_0001264)
-
Bile-salt-activated lipase / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2079.9363)
- Pancreas (UBERON_0001264)
- Chymotrypsin-like elastase family member 3B / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2095.9357)
- Pancreas (UBERON_0001264)
- Chymotrypsin-like elastase family member 3B / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2095.9357)
- Pancreas (UBERON_0001264)
- Chymotrypsin-like elastase family member 3B / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2136.9883)
- Pancreas (UBERON_0001264)
- Chymotrypsin-like elastase family member 3B / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2178.0409)
- Pancreas (UBERON_0001264)
- Chymotrypsin-like elastase family member 3B / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2224.0231)
- Pancreas (UBERON_0001264)
-
Bile-salt-activated lipase / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2242.0787)
- Pancreas (UBERON_0001264)
- Cancer, Bile duct (DOID:4606)
-
Pancreatic glycopeptides / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2283.1313)
- Pancreas (UBERON_0001264)
- Chymotrypsin-like elastase family member 3B / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2340.1833)
- Pancreas (UBERON_0001264)
- Chymotrypsin-like elastase family member 3B / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2370.1661)
- Pancreas (UBERON_0001264)
-
Bile-salt-activated lipase / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2915.7015)
- Pancreas (UBERON_0001264)
- Cancer, Bile duct (DOID:4606)
-
Pancreatic glycopeptides / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 3427.1819)
- Pancreas (UBERON_0001264)
- Cancer, Bile duct (DOID:4606)
-
Pancreatic glycopeptides / Homo sapiens
- Undefined site
-
- N-Linked / High-Mannose
(avg mass : 1235.1173)
- Pancreas (UBERON_0001264)
- Ribonuclease pancreatic [b] / Bos taurus
-
- N-Linked / High-Mannose
(avg mass : 1235.1173)
- Pancreas (UBERON_0001264)
-
Ribonuclease pancreatic [b] / Bos taurus
- Undefined site
-
- N-Linked / High-Mannose
(avg mass : 1397.2597)
- Pancreas (UBERON_0001264)
- Ribonuclease pancreatic [b] / Bos taurus
-
- N-Linked / High-Mannose
(avg mass : 1397.2597)
- Pancreas (UBERON_0001264)
-
Ribonuclease pancreatic [b] / Bos taurus
- Undefined site
-
- N-Linked / High-Mannose
(avg mass : 1559.4021)
- Pancreas (UBERON_0001264)
- Analysis of carbohydrate heterogeneity in a glycoprotein using liquid chromatography/mass spectrometry and liquid chromatography with tandem mass spectrometry. (1999 - Kawasaki N, Ohta M, Hyuga S, Hashimoto O, Hayakawa T) / Status : Reviewed
- A detailed structural characterization of ribonuclease B oligosaccharides by 1H NMR spectroscopy and mass spectrometry. (1994 - Fu D, Chen L, O'Neill R) / Status : Reviewed
- Ribonuclease pancreatic [b] / Bos taurus
-
- N-Linked / High-Mannose
(avg mass : 1559.4021)
- Pancreas (UBERON_0001264)
- Analysis of carbohydrate heterogeneity in a glycoprotein using liquid chromatography/mass spectrometry and liquid chromatography with tandem mass spectrometry. (1999 - Kawasaki N, Ohta M, Hyuga S, Hashimoto O, Hayakawa T) / Status : Reviewed
- A detailed structural characterization of ribonuclease B oligosaccharides by 1H NMR spectroscopy and mass spectrometry. (1994 - Fu D, Chen L, O'Neill R) / Status : Reviewed
- Ribonuclease pancreatic [b] / Bos taurus
-
- N-Linked / High-Mannose
(avg mass : 1559.4021)
- Pancreas (UBERON_0001264)
- Analysis of carbohydrate heterogeneity in a glycoprotein using liquid chromatography/mass spectrometry and liquid chromatography with tandem mass spectrometry. (1999 - Kawasaki N, Ohta M, Hyuga S, Hashimoto O, Hayakawa T) / Status : Reviewed
- A detailed structural characterization of ribonuclease B oligosaccharides by 1H NMR spectroscopy and mass spectrometry. (1994 - Fu D, Chen L, O'Neill R) / Status : Reviewed
- Ribonuclease pancreatic [b] / Bos taurus
-
- N-Linked / High-Mannose
(avg mass : 1559.4021)
- Pancreas (UBERON_0001264)
-
Ribonuclease pancreatic [b] / Bos taurus
- Undefined site
-
- N-Linked / High-Mannose
(avg mass : 1721.5445)
- Pancreas (UBERON_0001264)
- Ribonuclease pancreatic [b] / Bos taurus
-
- N-Linked / High-Mannose
(avg mass : 1721.5445)
- Pancreas (UBERON_0001264)
- Ribonuclease pancreatic [b] / Bos taurus
-
- N-Linked / High-Mannose
(avg mass : 1721.5445)
- Pancreas (UBERON_0001264)
- Ribonuclease pancreatic [b] / Bos taurus
-
- N-Linked / High-Mannose
(avg mass : 1721.5445)
- Pancreas (UBERON_0001264)
-
Ribonuclease pancreatic [b] / Bos taurus
- Undefined site
-
- N-Linked / High-Mannose
(avg mass : 1883.6869)
- Pancreas (UBERON_0001264)
- Ribonuclease pancreatic [b] / Bos taurus
-
- N-Linked / High-Mannose
(avg mass : 1883.6869)
- Pancreas (UBERON_0001264)
-
Ribonuclease pancreatic [b] / Bos taurus
- Undefined site
-
- N-Linked / Hybrid
(avg mass : 1600.4547)
- Pancreas (UBERON_0001264)
- Analysis of carbohydrate heterogeneity in a glycoprotein using liquid chromatography/mass spectrometry and liquid chromatography with tandem mass spectrometry. (1999 - Kawasaki N, Ohta M, Hyuga S, Hashimoto O, Hayakawa T) / Status : Reviewed
- The structure of N-linked oligosaccharides of human pancreatic bile-salt-dependent lipase. (1993 - Sugo T, Mas E, Abouakil N, Endo T, Escribano M, Kobata A, Lombardo D) / Status : Reviewed
-
Bile-salt-activated lipase / Homo sapiens
- Undefined site
- Ribonuclease pancreatic [b] / Bos taurus
-
- N-Linked / No-core
(avg mass : 1114.0275)
- Pancreas (UBERON_0001264)
-
- N-Linked / No-core
(avg mass : 1317.2225)
- Pancreas (UBERON_0001264)
-
- N-Linked / No-core
(avg mass : 1317.2225)
- Pancreas (UBERON_0001264)
-
- N-Linked / Pauci-Mannose
(avg mass : 1056.9755)
- Pancreas (UBERON_0001264)
- Chymotrypsin-like elastase family member 3B / Homo sapiens
-
- O-Linked / Core 1
(avg mass : 674.6106)
- Pancreas (UBERON_0001264)
- Pancreatitis, Chronic (DOID:4989)
-
Bile-salt-activated lipase / Homo sapiens
- Undefined site
-
- O-Linked / Core 1
(avg mass : 820.7536)
- Pancreas (UBERON_0001264)
- Pancreatitis, Chronic (DOID:4989)
-
Bile-salt-activated lipase / Homo sapiens
- Undefined site
-
- O-Linked / Core 1
(avg mass : 965.8685)
- Pancreas (UBERON_0001264)
- Pancreatitis, Chronic (DOID:4989)
-
Bile-salt-activated lipase / Homo sapiens
- Undefined site
-
- Hex:5 HexNAc:2 / N-Linked
(avg mass : 1235.1173)
- Pancreas (UBERON_0001264)
- N-Linked / High-Mannose / Man(a1-3)[Man(a1-6)]Man(a1-6)[Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / High-Mannose / Man(a1-3)[Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 2 x Man"
- Ribonuclease pancreatic [b] / Bos taurus
- NLTKDR (6aa)
-
- Hex:6 HexNAc:2 / N-Linked
(avg mass : 1397.2597)
- Pancreas (UBERON_0001264)
- N-Linked / High-Mannose / Man(a1-3)[Man(a1-6)]Man(a1-6)[Man(a1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / High-Mannose / Man(a1-3)[Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 3 x Man"
- Ribonuclease pancreatic [b] / Bos taurus
- NLTKDR (6aa)
-
- Hex:7 HexNAc:2 / N-Linked
(avg mass : 1559.4021)
- Pancreas (UBERON_0001264)
- N-Linked / High-Mannose / Man(a1-2)Man(a1-3)[Man(a1-6)]Man(a1-6)[Man(a1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / High-Mannose / Man(a1-2)Man(a1-6)[Man(a1-3)]Man(a1-6)[Man(a1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / High-Mannose / Man(a1-3)[Man(a1-6)]Man(a1-6)[Man(a1-2)Man(a1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / High-Mannose / Man(a1-3)[Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 4 x Man"
- Ribonuclease pancreatic [b] / Bos taurus
- NLTKDR (6aa)
-
- Hex:8 HexNAc:2 / N-Linked
(avg mass : 1721.5445)
- Pancreas (UBERON_0001264)
- N-Linked / High-Mannose / Man(a1-2)Man(a1-3)[Man(a1-2)Man(a1-6)]Man(a1-6)[Man(a1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / High-Mannose / Man(a1-2)Man(a1-3)[Man(a1-6)]Man(a1-6)[Man(a1-2)Man(a1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / High-Mannose / Man(a1-2)Man(a1-6)[Man(a1-3)]Man(a1-6)[Man(a1-2)Man(a1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / High-Mannose / Man(a1-3)[Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 5 x Man"
- Ribonuclease pancreatic [b] / Bos taurus
- NLTKDR (6aa)
-
- Hex:9 HexNAc:2 / N-Linked
(avg mass : 1883.6869)
- Pancreas (UBERON_0001264)
- N-Linked / High-Mannose / Man(a1-2)Man(a1-3)[Man(a1-2)Man(a1-6)]Man(a1-6)[Man(a1-2)Man(a1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / High-Mannose / Man(a1-3)[Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 6 x Man"
- Ribonuclease pancreatic [b] / Bos taurus
- NLTKDR (6aa)
-
- Hex:5 HexNAc:2 / N-Linked
(avg mass : 1235.1173)
- Pancreas (UBERON_0001264)
- N-Linked / High-Mannose / Man(a1-3)[Man(a1-6)]Man(a1-6)[Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / High-Mannose / Man(a1-3)[Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 2 x Man"
- Ribonuclease pancreatic [b] / Bos taurus
-
- Hex:6 HexNAc:2 / N-Linked
(avg mass : 1397.2597)
- Pancreas (UBERON_0001264)
- N-Linked / High-Mannose / Man(a1-3)[Man(a1-6)]Man(a1-6)[Man(a1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / High-Mannose / Man(a1-3)[Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 3 x Man"
- Ribonuclease pancreatic [b] / Bos taurus
-
- Hex:7 HexNAc:2 / N-Linked
(avg mass : 1559.4021)
- Pancreas (UBERON_0001264)
- N-Linked / High-Mannose / Man(a1-2)Man(a1-3)[Man(a1-6)]Man(a1-6)[Man(a1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / High-Mannose / Man(a1-2)Man(a1-6)[Man(a1-3)]Man(a1-6)[Man(a1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / High-Mannose / Man(a1-3)[Man(a1-6)]Man(a1-6)[Man(a1-2)Man(a1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / High-Mannose / Man(a1-3)[Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 4 x Man"
- Ribonuclease pancreatic [b] / Bos taurus
-
- Hex:8 HexNAc:2 / N-Linked
(avg mass : 1721.5445)
- Pancreas (UBERON_0001264)
- N-Linked / High-Mannose / Man(a1-2)Man(a1-3)[Man(a1-2)Man(a1-6)]Man(a1-6)[Man(a1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / High-Mannose / Man(a1-2)Man(a1-3)[Man(a1-6)]Man(a1-6)[Man(a1-2)Man(a1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / High-Mannose / Man(a1-2)Man(a1-6)[Man(a1-3)]Man(a1-6)[Man(a1-2)Man(a1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / High-Mannose / Man(a1-3)[Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 5 x Man"
- Ribonuclease pancreatic [b] / Bos taurus
-
- Hex:6 HexNAc:3 dHex:1 / N-Linked
(avg mass : 1746.5977)
- Pancreas (UBERON_0001264)
- Ribonuclease pancreatic [b] / Bos taurus
-
- Hex:9 HexNAc:2 / N-Linked
(avg mass : 1883.6869)
- Pancreas (UBERON_0001264)
- N-Linked / High-Mannose / Man(a1-2)Man(a1-3)[Man(a1-2)Man(a1-6)]Man(a1-6)[Man(a1-2)Man(a1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / High-Mannose / Man(a1-3)[Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 6 x Man"
- Ribonuclease pancreatic [b] / Bos taurus
Source
Suggested structure
Reported glycosite
- Hex:9 HexNAc:2 / N-Linked
(avg mass : 1883.6869)
Source
Suggested structure
Reported glycosite
- Hex:6 HexNAc:3 dHex:1 / N-Linked
(avg mass : 1746.5977)
Source
Suggested structure
Reported glycosite
- Hex:8 HexNAc:2 / N-Linked
(avg mass : 1721.5445)
Source
Suggested structure
Reported glycosite
- Hex:7 HexNAc:2 / N-Linked
(avg mass : 1559.4021)
Source
Suggested structure
Reported glycosite
- Hex:6 HexNAc:2 / N-Linked
(avg mass : 1397.2597)
Source
Suggested structure
Reported glycosite
- Hex:5 HexNAc:2 / N-Linked
(avg mass : 1235.1173)
Source
Suggested structure
Reported glycosite
Mass spectrometry observed peptide
- Hex:9 HexNAc:2 / N-Linked
(avg mass : 1883.6869)
Source
Suggested structure
Reported glycosite
Mass spectrometry observed peptide
- Hex:8 HexNAc:2 / N-Linked
(avg mass : 1721.5445)
Source
Suggested structure
Reported glycosite
Mass spectrometry observed peptide
- Hex:7 HexNAc:2 / N-Linked
(avg mass : 1559.4021)
Source
Suggested structure
Reported glycosite
Mass spectrometry observed peptide
- Hex:6 HexNAc:2 / N-Linked
(avg mass : 1397.2597)
Source
Suggested structure
Reported glycosite
Mass spectrometry observed peptide
- Hex:5 HexNAc:2 / N-Linked
(avg mass : 1235.1173)
Source
Disease
Reported glycosite
- O-Linked / Core 1
(avg mass : 965.8685)
Source
Disease
Reported glycosite
- O-Linked / Core 1
(avg mass : 820.7536)
Source
Disease
Reported glycosite
- O-Linked / Core 1
(avg mass : 674.6106)
Source
Reported glycosite
- N-Linked / Pauci-Mannose
(avg mass : 1056.9755)
Source
Reported glycosite
- N-Linked / No-core
(avg mass : 1317.2225)
Source
Reported glycosite
- N-Linked / No-core
(avg mass : 1317.2225)
Source
Reported glycosite
- N-Linked / No-core
(avg mass : 1114.0275)
Source
Reference
Reported glycosite
- N-Linked / Hybrid
(avg mass : 1600.4547)
Source
Reported glycosite
- N-Linked / High-Mannose
(avg mass : 1883.6869)
Source
Reported glycosite
- N-Linked / High-Mannose
(avg mass : 1883.6869)
Source
Reported glycosite
- N-Linked / High-Mannose
(avg mass : 1721.5445)
Source
Reported glycosite
- N-Linked / High-Mannose
(avg mass : 1721.5445)
Source
Reported glycosite
- N-Linked / High-Mannose
(avg mass : 1721.5445)
Source
Reported glycosite
- N-Linked / High-Mannose
(avg mass : 1721.5445)
Source
Reported glycosite
- N-Linked / High-Mannose
(avg mass : 1559.4021)
Source
Reference
Reported glycosite
- N-Linked / High-Mannose
(avg mass : 1559.4021)
Source
Reference
Reported glycosite
- N-Linked / High-Mannose
(avg mass : 1559.4021)
Source
Reference
Reported glycosite
- N-Linked / High-Mannose
(avg mass : 1559.4021)
Source
Reported glycosite
- N-Linked / High-Mannose
(avg mass : 1397.2597)
Source
Reported glycosite
- N-Linked / High-Mannose
(avg mass : 1397.2597)
Source
Reported glycosite
- N-Linked / High-Mannose
(avg mass : 1235.1173)
Source
Reported glycosite
- N-Linked / High-Mannose
(avg mass : 1235.1173)
Source
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 3427.1819)
Source
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 2915.7015)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2370.1661)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2340.1833)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2283.1313)
Source
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 2242.0787)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2224.0231)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2178.0409)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2136.9883)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2095.9357)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2095.9357)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2079.9363)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2078.9082)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2006.8447)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 1990.8453)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 1974.8459)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 1933.7933)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 1933.7933)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 1933.7933)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 1932.7652)
Source
Reference
Reported glycosite
- N-Linked / Complex
(avg mass : 1787.6503)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 1787.6503)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 1771.6509)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 1641.5073)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 1625.5079)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 1625.5079)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 1625.5079)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 1479.3649)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 1463.3655)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 1422.3129)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 1260.1705)
